Abstract
In a letter published in the July/August 2004 issue (2004;38:1317-8%), the following author should be included: Barry G Saver MD MPH, Associate Professor, Department of Family Medicine, University of Washington, Seattle, Washington.
Letters are subject to review prior to acceptance. They should address areas related to pharmacy practice, research, or education, or articles recently published. Corrections of previously published material also are accepted. Letters are limited to no more than five authors. In cases where adverse drug effects are described, the Naranjo ADR probability scale should be used to determine the likelihood that the adverse effect was drug-related (Clin Pharmacol Ther 1981;30:239-45%). Text: limit 500 words. References: limit 5. Art: limit 1 table or figure.